AFP and hepatocellular carcinoma: In our study, first, the clinical outcomes and prognosis of clinical HCC patients with or without MVI were compared and analyzed; then, based on preoperative AFP, tumor diameter, and TNM stage, an MVI prediction model with superior predictive efficacy was constructed and validated, which provided a new therapeutic strategy for the comprehensive and standardized treatment of HCC patients.